CHAUHAN, S. et al. Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus . Academia Journal of Medicine, v. 4, n. 2, p. 50–54, 31 Dec.2022.